PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.42
Similar ESG score to RNAZ's 63.21. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
57.61
Similar environmental score to RNAZ's 55.41. Bruce Berkowitz would investigate if industry environmental norms adequately address climate transition risks.
61.21
Social score 90-95% of RNAZ's 67.22. Bill Ackman would demand clear social improvement catalysts.
62.44
Governance score 90-95% of RNAZ's 67.01. Bill Ackman would demand clear governance improvement catalysts.